10x Genomics
10x Genomics is a biotechnology company specializing in developing innovative solutions for genomic analysis.
Services
10x Genomics provides advanced genomics solutions designed to accelerate scientific discoveries and understanding. The company offers a range of products and technologies focused on single-cell analysis, spatial biology, and linked-read sequencing. These solutions enable researchers to examine complex biological systems at single-cell and molecular levels, facilitating breakthroughs in areas such as oncology, immunology, and neuroscience.
Founders
10x Genomics was founded by Serge Saxonov, Ben Hindson, and Kevin Ness. These individuals brought together their expertise in genomics, technology, and engineering to establish the company. Their combined knowledge and experience in the field of genomics have been instrumental in the development and success of the company's innovative technologies.
Products
10x Genomics offers a variety of products to support advanced genomic research. Key products include the Chromium Single Cell System, Visium Spatial Gene Expression Solution, and the Linked-Reads application. These products are designed to handle large, complex data sets, providing researchers with precise and comprehensive insights into cellular and molecular mechanisms.
Sector
10x Genomics operates within the biotechnology and life sciences sector. The company focuses on developing innovative genomic technologies that enhance scientific research and discovery. Their solutions are widely used in academic research, pharmaceutical studies, and clinical diagnostics, contributing to significant advancements in medical and biological sciences.
History
10x Genomics was founded in 2012 and has since become a leader in the genomic solutions market. The company has grown rapidly, driven by the demand for sophisticated tools to explore genetic information at unprecedented resolution. Over the years, 10x Genomics has expanded its product offerings and collaborated with various research institutions to further the capabilities of genomic research.